News for BriaCell Therapeutics Corp. (BCTX)

Stocks Analysis by MarketBeat.com (Nathan Reiff) covering: Briacell Therapeutics Corp, Recursion Pharmaceuticals Inc. Read MarketBeat.com (Nathan Reiff)'s latest article on Investing.com

**media[533568]**

PHILADELPHIA, Pa. and VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) —

Shares of Palantir Technologies Inc. PLTR rose sharply in today's pre-market trading following better-than-expected fourth-quarter results. Palantir reported f...

BriaCell Therapeutics prices public offering at $4 per share, expecting $3.05M in proceeds for business objectives.

**media[531248]**

**media[531193]**

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTSâ„¢ monotherapyNo toxicity related to the tre

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 27, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“

BCTX stock touches 52-week low at $0.46 amid sharp annual decline

Shares of Smart Share Global Limited EM rose sharply in today's pre-market trading after the company announced the receipt of a preliminary non-binding proposal...

**media[505245]**

**media[505244]**

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“

**media[491810]**

BriaCell reports influx of cancer fighting CD8+ ”œkiller” T cell into metastatic breast cancer tumors and lymph organs turning ”œCold” tumors and lymph no

Shares of DBV Technologies S.A. DBVT rose sharply in the pre-market trading after the company announced alignment with the FDA on an accelerated approval pathwa...

Shares of JD.com, Inc. JD rose sharply in today's pre-market. Shares of US-listed Chinese stocks traded higher on continued strength following recent stimulus ...